PolyPeptide Group AG (PPGN)

Switzerland
Currency in CHF
22.60
-0.85(-3.62%)
Closed
PPGN Scorecard
Full Analysis
RSI suggests the stock is in oversold territory
Fair Value
Day's Range
22.6023.35
52 wk Range
15.4835.80
Key Statistics
Edit
Bid/Ask
22.00 / 23.50
Prev. Close
22.6
Open
23.1
Day's Range
22.6-23.35
52 wk Range
15.48-35.8
Volume
27.41K
Average Volume (3m)
25.79K
1-Year Change
41.52%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PPGN Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
35.94
Upside
+59.03%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

PolyPeptide Group AG Company Profile

PolyPeptide Group AG operate as a contract development and manufacturing company in Europe, the United States, and India. It develops and manufactures synthetic peptides and oligonucleotides used as active pharmaceutical ingredients or intermediates in therapeutic products for pharmaceutical and biotech companies. The company offers portfolio of peptide-based therapies for metabolic disorders, including the GLP-1 receptor agonist drugs for the treatment of type 2 diabetes, obesity, and other co-morbidities, as well as oncology, hormonal disorders, neurology, ophthalmology, cardiovascular, and gastrointestinal applications. It also provides peptides for cosmetics; and individualized peptide therapeutics. The company was founded in 1952 and is headquartered in Baar, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.

Employees
1277

Compare PPGN to Peers and Sector

Metrics to compare
PPGN
Peers
Sector
Relationship
P/E Ratio
−28.2x−2.9x−0.6x
PEG Ratio
−1.290.060.00
Price/Book
2.2x2.2x2.6x
Price / LTM Sales
2.5x5.5x3.1x
Upside (Analyst Target)
60.2%11.9%48.7%
Fair Value Upside
Unlock8.0%7.7%Unlock

Analyst Ratings

3 Buy
1 Hold
1 Sell
Ratings:
5 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 35.94
(+59.03% Upside)

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the PolyPeptide Group AG (PPGN) Stock Price Today?

The PolyPeptide Group AG stock price today is 22.60.

What Stock Exchange Does PolyPeptide Group AG Trade On?

PolyPeptide Group AG is listed and trades on the Switzerland stock exchange.

What Is the Stock Symbol for PolyPeptide Group AG?

The stock symbol for PolyPeptide Group AG is "PPGN."

What Is the PolyPeptide Group AG Market Cap?

As of today, PolyPeptide Group AG market cap is 745.43M.

What is PolyPeptide Group AG Earnings Per Share?

The PolyPeptide Group AG EPS is -0.873.

From a Technical Analysis Perspective, Is PPGN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.